Neuropace, Inc. NPCE Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s operating lease right-of-use asset amortization?
- Neuropace, Inc. (NPCE) reported operating lease right-of-use asset amortization of $453K in Q1 2026.
- How has Neuropace, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Neuropace, Inc.'s operating lease right-of-use asset amortization increased by 9.7% year-over-year, from $413K to $453K.